39 tracked 13F filers disclose a position in IMA as of the latest SEC 13F filings, a combined $30.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BVF INC/IL | $5.6M | 1.1M | ▲+38% Added · +308K sh | Q1 2026 | |
| 2 | Blue Owl Capital Holdings LP | $5.4M | 918K | ▼−4.3% Reduced · −42K sh | Q2 2026 | |
| 3 | Cable Car Capital, LP | $4.6M | 782K | ▲+3.5% Added · +27K sh | Q2 2026 | |
| 4 | Omega Fund Management, LLC | $2.3M | 455K | —Held | Q1 2026 | |
| 5 | ORBIMED ADVISORS LLC | $1.9M | 379K | —Held | Q1 2026 | |
| 6 | RTW INVESTMENTS, LP | $2.0M | 334K | —Held | Q2 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $1.6M | 325K | →First observed position No prior filed position | Q1 2026 | |
| 8 | Trails Edge Capital Partners, LP | $1.7M | 282K | ▲New +282K sh | Q2 2026 | |
| 9 | BML Capital Management, LLC | $1.2M | 201K | —Held | Q2 2026 | |
| 10 | BlackRock, Inc. | $646K | 129K | ▼−1.8% Reduced · −2K sh | Q1 2026 | |
| 11 | CITADEL ADVISORS LLC | $622K | 124K | ▲+44% Added · +38K sh | Q1 2026 | |
| 12 | RENAISSANCE TECHNOLOGIES LLC | $408K | 82K | ▲+24% Added · +16K sh | Q1 2026 | |
| 13 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $333K | 67K | —Held | Q1 2026 | |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | $316K | 54K | ▼−11% Reduced · −6K sh | Q2 2026 | |
| 15 | NEA Management Company, LLC | $250K | 50K | —Held | Q1 2026 | |
| 16 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | $295K | 50K | ▲+67% Added · +20K sh | Q2 2026 | |
| 17 | HSBC HOLDINGS PLC | $166K | 35K | ▲+1.9% Added · +656 sh | Q1 2026 | |
| 18 | Rangeley Capital, LLC | $163K | 33K | ▲+79% Added · +14K sh | Q1 2026 | |
| 19 | Sofinnova Investments, Inc. | $188K | 32K | —Held | Q2 2026 | |
| 20 | VANGUARD FIDUCIARY TRUST CO | $136K | 27K | →First observed position No prior filed position | Q1 2026 | |
| 21 | JACOBS LEVY EQUITY MANAGEMENT, INC | $133K | 27K | ▲+42% Added · +8K sh | Q1 2026 | |
| 22 | Shay Capital LLC | $96K | 19K | ▼−18% Reduced · −4K sh | Q1 2026 | |
| 23 | MORGAN STANLEY | $92K | 18K | ▲+70% Added · +8K sh | Q1 2026 | |
| 24 | Aldebaran Capital, LLC | $107K | 18K | ▼−2.4% Reduced · −442 sh | Q2 2026 | |
| 25 | XTX Topco Ltd | $76K | 15K | ▲+24% Added · +3K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 2 funds opened a new position in IMA and 9 added to an existing one, while 4 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS INFDMT | 11 funds | $86.8M |
| ONKURE THERAPEUTICS INC-AOKUR | 11 funds | $26.2M |
| NVIDIA CORPNVDA | 10 funds | $9.5B |
| MICROSOFT CORPMSFT | 10 funds | $4.4B |
| MICRON TECHNOLOGY INCMU | 10 funds | $3.3B |
| TESLA INCTSLA | 10 funds | $2.1B |
| ELI LILLY & COLLY | 10 funds | $1.4B |
| REVOLUTION MEDICINES INCRVMD | 10 funds | $881.0M |
| ELEVANCE HEALTH INCELV | 10 funds | $555.7M |
| DANAHER CORPDHR | 10 funds | $517.5M |
| GUARDANT HEALTH INCGH | 10 funds | $446.0M |
| BRISTOL-MYERS SQUIBB COBMY | 10 funds | $395.9M |
Ranked by how many of IMA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | Lally Robert B | Principal Accounting Officer | Sell (S) | 2K | $8K |
| Jul 16, 2026 | Lally Robert B | Principal Accounting Officer | Sell (S) | 2K | $9K |
| Dec 24, 2025 | SLATTERY JOSEPH P | Director | Buy (P) | 16K | $96K |
| Jul 25, 2025 | Stampacchia Otello | Director | Buy (P) | 268K | $8.0M |
| Jul 25, 2025 | Bonita David P | Director | Buy (P) | 84K | $2.5M |
| May 17, 2010 | HEMPEL PAUL T | Sr VP, LD & Legal Affairs | Sell (S) | 100 | $4K |
| May 17, 2010 | HEMPEL PAUL T | Sr VP, LD & Legal Affairs | Sell (S) | 745 | $28K |
| May 17, 2010 | HEMPEL PAUL T | Sr VP, LD & Legal Affairs | Sell (S) | 300 | $11K |
| Feb 19, 2010 | TOWNSEND PETER | Director | Sell (S) | 8K | $328K |
| Jun 16, 2009 | MCALEER JEROME F | VP, Research & Development, Director | Buy (S) | 40K | $1.3M |
| Jun 16, 2009 | SCOTT DAVID | Chief Technical Officer, Director | Sell (S) | 23K | $732K |
| Jun 16, 2009 | KHEDERIAN ROBERT P | Director | Sell (S) | 25K | $819K |
Connected entities for IMA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/IMA/capital-change-brief"
Use Arkolith's capital_change_brief for IMA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for IMA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.